Prevalence of immune-related adverse events and anti-tumor efficacy in advanced/metastatic urothelial carcinoma following immune-checkpoint inhibitor treatment

被引：0
|
作者：
Rafael Morales-Barrera
Guillermo Villacampa
Natalia Vidal
Mariona Figols
Julia Giner
Teresa Bonfill
Cristina Suárez
Nely Díaz
Joaquín Mateo
Macarena González
Montserrat Domenech
Javier Puente
Joan Carles
机构：
[1] Vall d’Hebron Institute of Oncology,Department of Medical Oncology
[2] Vall d’ Hebron University Hospital,Oncology Data Science (OdysSey) Group
[3] Universitat Autònoma de Barcelona,Medical Oncology Department
[4] Vall d’Hebron Institute of Oncology (VHIO),Medical Oncology Department
[5] The Institute of Cancer Research,Medical Oncology
[6] Hospital Clínico San Carlos,undefined
[7] Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC),undefined
[8] CIBERONC,undefined
[9] Fundació Althaia Manresa,undefined
[10] Parc Taulí Hospital Universitari,undefined
[11] Institut d’Investigació i Innovació Parc Taulí I3PT,undefined
来源：
Clinical and Translational Oncology | 2023年 / 25卷
关键词：
Immune checkpoint inhibitors; Immune-related adverse events; Overall response rate; Survival; Urothelial carcinoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3556 / 3564
页数：8
相关论文
共 50 条
  • [41] Local treatment on the outcome of immune-checkpoint inhibitors in metastatic urothelial carcinoma
    Maldonado, J.
    Morales Barrera, R.
    Vidal, N.
    Feltes, N.
    Domenech, M.
    Puente, J.
    Figols, M.
    Gonzalez, M.
    Lozano, F.
    Lopez, H.
    Gallardo, E.
    Moreno, D.
    Suarez, C.
    Morote, J.
    Carles, J.
    Giralt, J.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S637 - S638
  • [42] The correlation between immune-related adverse events and efficacy of immune checkpoint inhibitors
    Fukushima, Taito
    Kobayashi, Satoshi
    Ueno, Makoto
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024, 54 (09) : 949 - 958
  • [43] Incidence and Timing of Immune-Related Adverse Events in Immune-Checkpoint Inhibitor-Treated Patients: A Retrospective Observational Study
    Masaki, Kou
    Miyazaki, Motoyasu
    Kakimoto, Hideki
    Fukiage, Yuma
    Fukue, Haruka
    Nakashima, Akio
    Imakyure, Osamu
    Sparreboom, Alex
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (24)
  • [44] Immune-related adverse events: promising predictors for efficacy of immune checkpoint inhibitors
    Zhong, Li
    Wu, Qing
    Chen, Fuchun
    Liu, Junjin
    Xie, Xianhe
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (09) : 2559 - 2576
  • [45] Immune-related adverse events: promising predictors for efficacy of immune checkpoint inhibitors
    Li Zhong
    Qing Wu
    Fuchun Chen
    Junjin Liu
    Xianhe Xie
    Cancer Immunology, Immunotherapy, 2021, 70 : 2559 - 2576
  • [46] Autoantibody positivity predicts severity of rheumatic immune-related adverse events to immune-checkpoint inhibitors
    Campochiaro, Corrado
    Farina, Nicola
    Tomelleri, Alessandro
    Ferrara, Roberto
    Viola, Silvia
    Lazzari, Chiara
    De Luca, Giacomo
    Raggi, Daniele
    Bulotta, Alessandra
    Matucci-Cerinic, Marco
    Necchi, Andrea
    Garassino, Marina
    Gregorc, Vanesa
    Dagna, Lorenzo
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2022, 103 : 95 - 99
  • [47] Predictive biomarkers for immune-related adverse events in cancer patients treated with immune-checkpoint inhibitors
    Jingting Wang
    Yan Ma
    Haishan Lin
    Jing Wang
    Bangwei Cao
    BMC Immunology, 25
  • [48] Intrahepatic Bile Duct Injury as a Hepatic Immune-Related Adverse Event after Immune-Checkpoint Inhibitor Treatment
    Murayama, Aiko
    Tajiri, Kazuto
    Nakaya, Atsuko
    Ito, Hiroyuki
    Hayashi, Yuka
    Entani, Toshiki
    Nagata, Kohei
    Tanaka, Shinichi
    Hamashima, Takeru
    Yasuda, Ichiro
    CASE REPORTS IN GASTROENTEROLOGY, 2021, 15 (02) : 645 - 651
  • [49] Predictive biomarkers for immune-related adverse events in cancer patients treated with immune-checkpoint inhibitors
    Wang, Jingting
    Ma, Yan
    Lin, Haishan
    Wang, Jing
    Cao, Bangwei
    BMC IMMUNOLOGY, 2024, 25 (01)
  • [50] Prevalence, Therapy and Tumor Response in Patients with Rheumatic Immune-related Adverse Events Following Immune Checkpoint Inhibitor Therapy: A Single-Centre Analysis
    Verspohl, Sophia
    Holderried, Tobias
    Behning, Charlotte
    Brossart, Peter
    Schaefer, Valentin
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
12345